Skip to main content
MBBS DegreeFaculty of Faculty of Medical, Health & Clinical SciencesMedicine & Surgery

PHA 301: Systemic Pharmacology: Autonomic, Cardiovascular & Chemotherapeutic Agents (300 Level)

Therapeutic drug classes: ANS drugs, antihypertensives, antiarrhythmics, heart failure drugs, antimicrobials, antineoplastics, and immunosuppressants.

Instructor
Created by PAMCET Learning Team
intermediate1 weekEnglish

Course Overview

Therapeutic drug classes: ANS drugs, antihypertensives, antiarrhythmics, heart failure drugs, antimicrobials, antineoplastics, and immunosuppressants. Curriculum Structure & Core Modules: • 1. Autonomic Pharmacology: Cholinergic Agonists, Antagonists, Neuromuscular Blockers &...

What You'll Learn

  • Explain the receptor mechanisms, hemodynamic effects, and indications of adrenergic and cholinergic agents.
  • Rationalize combination pharmacotherapy in essential hypertension, heart failure, and ischemic heart disease.
  • Compare classes of antibacterial drugs regarding mechanism of action, antimicrobial spectrum, and toxicities.
  • Detail artemisinin-based combination therapies (ACTs) and second-line antimalarials in severe malaria.
  • Describe the cellular mechanisms and dose-limiting toxicities of antineoplastic alkylating agents and antimetabolites.

Requirements

  • Passing of 1st Professional MBBS Examination
  • PHA 201 credit

Degree Programme Curriculum Context

This course is a curriculum unit of the Bachelor of Medicine, Bachelor of Surgery (MBBS) degree framework in Nigeria.

Earn Your Certificate

Showcase your skills with a certificate! Complete the course, submit your project, and earn your certificate. Here's a sample of what you'll receive to show off your accomplishments.

course-certificate
Lecture Board & Syllabus

Course Curriculum

Browse complete theoretical foundations, worked calculations, laboratory protocols, and board assessment questions under each topic.

Launch Course Reader →
8 Chapters
•
16 Lecture
•
0s
Subtopic 1Document LectureOpen Access~27 min read

Autonomic Pharmacology: Cholinergic Agonists, Antagonists, Neuromuscular Blockers & Organophosphates: Structural Principles & Pathophysiological Derangements

PHA 301 • 300L • Pharmacology • Chapter 1 • Lecture 1 Autonomic Pharmacology: Cholinergic Agonists, Antagonists, Neuromuscular Blockers & Organophosphates: Structural Principles, Functional Architecture & Pathophysiological Derangements Curriculum Reference: PHA 301: Systemic Pharmacology: Autonomic, Cardiovascular & Chemotherapeutic Agents (300 Level) • Medical Ph...

Module 1 • Subtopic 1•22,299 characters of authentic academic content
Subtopic 2Document Lecture

Autonomic Pharmacology: Cholinergic Agonists, Antagonists, Neuromuscular Blockers & Organophosphates: Clinical Semiology, Differential Diagnosis & Evidence-Based Management

PHA 301 • 300L • Pharmacology • Chapter 1 • Lecture 2 Autonomic Pharmacology: Cholinergic Agonists, Antagonists, Neuromuscular Blockers & Organophosphates: Clinical Semiology, Differential Diagnosis & Evidence-Based Bedside Management Curriculum Reference: PHA 301: Systemic Pharmacology: Autonomic, Cardiovascular & Chemotherapeutic Agents (300 Level) • MDCN Profess...

Module 1 • Subtopic 2
Formative Assessment10 Points • 15 Mins

Autonomic Pharmacology: Cholinergic Agonists, Antagonists, Neuromuscular Blockers & Organophosphates: Formative Clinical Case Assessment

Assessment Protocol:10 Total Points•70% Passing Threshold•15 Mins Time Limit•Bloom's Taxonomy: Analyze & Evaluate

Authentic clinical vignette self-assessment evaluating semiology, diagnostic decision-making, and therapeutics for Autonomic Pharmacology: Cholinergic Agonists, Antagonists, Neuromuscular Blockers & Organophosphates.

Module 1 • Formative Assessment
Subtopic 1Document LectureOpen Access~26 min read

Adrenergic Pharmacology: Alpha/Beta Agonists, Antagonists & Clinical Vasopressors/Inotropes: Structural Principles & Pathophysiological Derangements

PHA 301 • 300L • Pharmacology • Chapter 2 • Lecture 1 Adrenergic Pharmacology: Alpha/Beta Agonists, Antagonists & Clinical Vasopressors/Inotropes: Structural Principles, Functional Architecture & Pathophysiological Derangements Curriculum Reference: PHA 301: Systemic Pharmacology: Autonomic, Cardiovascular & Chemotherapeutic Agents (300 Level) • Medical Pharmacolog...

Module 2 • Subtopic 1•21,598 characters of authentic academic content
Subtopic 2Document Lecture

Adrenergic Pharmacology: Alpha/Beta Agonists, Antagonists & Clinical Vasopressors/Inotropes: Clinical Semiology, Differential Diagnosis & Evidence-Based Management

PHA 301 • 300L • Pharmacology • Chapter 2 • Lecture 2 Adrenergic Pharmacology: Alpha/Beta Agonists, Antagonists & Clinical Vasopressors/Inotropes: Clinical Semiology, Differential Diagnosis & Evidence-Based Bedside Management Curriculum Reference: PHA 301: Systemic Pharmacology: Autonomic, Cardiovascular & Chemotherapeutic Agents (300 Level) • MDCN Professional MBB...

Module 2 • Subtopic 2
Formative Assessment10 Points • 15 Mins

Adrenergic Pharmacology: Alpha/Beta Agonists, Antagonists & Clinical Vasopressors/Inotropes: Formative Clinical Case Assessment

Assessment Protocol:10 Total Points•70% Passing Threshold•15 Mins Time Limit•Bloom's Taxonomy: Analyze & Evaluate

Authentic clinical vignette self-assessment evaluating semiology, diagnostic decision-making, and therapeutics for Adrenergic Pharmacology: Alpha/Beta Agonists, Antagonists & Clinical Vasopressors/Inotropes.

Module 2 • Formative Assessment
Subtopic 1Document LectureOpen Access~27 min read

Cardiovascular Drugs I: Antihypertensive Classes (ACEi, ARBs, CCBs, Thiazides, Central Agonists): Structural Principles & Pathophysiological Derangements

PHA 301 • 300L • Pharmacology • Chapter 3 • Lecture 1 Cardiovascular Drugs I: Antihypertensive Classes (ACEi, ARBs, CCBs, Thiazides, Central Agonists): Structural Principles, Functional Architecture & Pathophysiological Derangements Curriculum Reference: PHA 301: Systemic Pharmacology: Autonomic, Cardiovascular & Chemotherapeutic Agents (300 Level) • Medical Pharmacolo...

Module 3 • Subtopic 1•22,216 characters of authentic academic content
Subtopic 2Document Lecture

Cardiovascular Drugs I: Antihypertensive Classes (ACEi, ARBs, CCBs, Thiazides, Central Agonists): Clinical Semiology, Differential Diagnosis & Evidence-Based Management

PHA 301 • 300L • Pharmacology • Chapter 3 • Lecture 2 Cardiovascular Drugs I: Antihypertensive Classes (ACEi, ARBs, CCBs, Thiazides, Central Agonists): Clinical Semiology, Differential Diagnosis & Evidence-Based Bedside Management Curriculum Reference: PHA 301: Systemic Pharmacology: Autonomic, Cardiovascular & Chemotherapeutic Agents (300 Level) • MDCN Professional MB...

Module 3 • Subtopic 2
Formative Assessment10 Points • 15 Mins

Cardiovascular Drugs I: Antihypertensive Classes (ACEi, ARBs, CCBs, Thiazides, Central Agonists): Formative Clinical Case Assessment

Assessment Protocol:10 Total Points•70% Passing Threshold•15 Mins Time Limit•Bloom's Taxonomy: Analyze & Evaluate

Authentic clinical vignette self-assessment evaluating semiology, diagnostic decision-making, and therapeutics for Cardiovascular Drugs I: Antihypertensive Classes (ACEi, ARBs, CCBs, Thiazides, Central Agonists).

Module 3 • Formative Assessment
Subtopic 1Document LectureOpen Access~26 min read

Cardiovascular Drugs II: Antiarrhythmics (Vaughan-Williams), Anti-Anginals & Lipid-Lowering Statins: Structural Principles & Pathophysiological Derangements

PHA 301 • 300L • Pharmacology • Chapter 4 • Lecture 1 Cardiovascular Drugs II: Antiarrhythmics (Vaughan-Williams), Anti-Anginals & Lipid-Lowering Statins: Structural Principles, Functional Architecture & Pathophysiological Derangements Curriculum Reference: PHA 301: Systemic Pharmacology: Autonomic, Cardiovascular & Chemotherapeutic Agents (300 Level) • Medical Pha...

Module 4 • Subtopic 1•21,646 characters of authentic academic content
Subtopic 2Document Lecture

Cardiovascular Drugs II: Antiarrhythmics (Vaughan-Williams), Anti-Anginals & Lipid-Lowering Statins: Clinical Semiology, Differential Diagnosis & Evidence-Based Management

PHA 301 • 300L • Pharmacology • Chapter 4 • Lecture 2 Cardiovascular Drugs II: Antiarrhythmics (Vaughan-Williams), Anti-Anginals & Lipid-Lowering Statins: Clinical Semiology, Differential Diagnosis & Evidence-Based Bedside Management Curriculum Reference: PHA 301: Systemic Pharmacology: Autonomic, Cardiovascular & Chemotherapeutic Agents (300 Level) • MDCN Professi...

Module 4 • Subtopic 2
Formative Assessment10 Points • 15 Mins

Cardiovascular Drugs II: Antiarrhythmics (Vaughan-Williams), Anti-Anginals & Lipid-Lowering Statins: Formative Clinical Case Assessment

Assessment Protocol:10 Total Points•70% Passing Threshold•15 Mins Time Limit•Bloom's Taxonomy: Analyze & Evaluate

Authentic clinical vignette self-assessment evaluating semiology, diagnostic decision-making, and therapeutics for Cardiovascular Drugs II: Antiarrhythmics (Vaughan-Williams), Anti-Anginals & Lipid-Lowering Statins.

Module 4 • Formative Assessment
Subtopic 1Document LectureOpen Access~27 min read

Antimicrobial Chemotherapy I: Cell Wall Inhibitors (Penicillins, Cephalosporins, Carbapenems, Vancomycin): Structural Principles & Pathophysiological Derangements

PHA 301 • 300L • Pharmacology • Chapter 5 • Lecture 1 Antimicrobial Chemotherapy I: Cell Wall Inhibitors (Penicillins, Cephalosporins, Carbapenems, Vancomycin): Structural Principles, Functional Architecture & Pathophysiological Derangements Curriculum Reference: PHA 301: Systemic Pharmacology: Autonomic, Cardiovascular & Chemotherapeutic Agents (300 Level) • Medical P...

Module 5 • Subtopic 1•22,355 characters of authentic academic content
Subtopic 2Document Lecture

Antimicrobial Chemotherapy I: Cell Wall Inhibitors (Penicillins, Cephalosporins, Carbapenems, Vancomycin): Clinical Semiology, Differential Diagnosis & Evidence-Based Management

PHA 301 • 300L • Pharmacology • Chapter 5 • Lecture 2 Antimicrobial Chemotherapy I: Cell Wall Inhibitors (Penicillins, Cephalosporins, Carbapenems, Vancomycin): Clinical Semiology, Differential Diagnosis & Evidence-Based Bedside Management Curriculum Reference: PHA 301: Systemic Pharmacology: Autonomic, Cardiovascular & Chemotherapeutic Agents (300 Level) • MDCN Profes...

Module 5 • Subtopic 2
Formative Assessment10 Points • 15 Mins

Antimicrobial Chemotherapy I: Cell Wall Inhibitors (Penicillins, Cephalosporins, Carbapenems, Vancomycin): Formative Clinical Case Assessment

Assessment Protocol:10 Total Points•70% Passing Threshold•15 Mins Time Limit•Bloom's Taxonomy: Analyze & Evaluate

Authentic clinical vignette self-assessment evaluating semiology, diagnostic decision-making, and therapeutics for Antimicrobial Chemotherapy I: Cell Wall Inhibitors (Penicillins, Cephalosporins, Carbapenems, Vancomycin).

Module 5 • Formative Assessment
Subtopic 1Document LectureOpen Access~26 min read

Antimicrobial Chemotherapy II: Protein Synthesis Inhibitors (Aminoglycosides, Macrolides, Tetracyclines): Structural Principles & Pathophysiological Derangements

PHA 301 • 300L • Pharmacology • Chapter 6 • Lecture 1 Antimicrobial Chemotherapy II: Protein Synthesis Inhibitors (Aminoglycosides, Macrolides, Tetracyclines): Structural Principles, Functional Architecture & Pathophysiological Derangements Curriculum Reference: PHA 301: Systemic Pharmacology: Autonomic, Cardiovascular & Chemotherapeutic Agents (300 Level) • Medical Ph...

Module 6 • Subtopic 1•21,691 characters of authentic academic content
Subtopic 2Document Lecture

Antimicrobial Chemotherapy II: Protein Synthesis Inhibitors (Aminoglycosides, Macrolides, Tetracyclines): Clinical Semiology, Differential Diagnosis & Evidence-Based Management

PHA 301 • 300L • Pharmacology • Chapter 6 • Lecture 2 Antimicrobial Chemotherapy II: Protein Synthesis Inhibitors (Aminoglycosides, Macrolides, Tetracyclines): Clinical Semiology, Differential Diagnosis & Evidence-Based Bedside Management Curriculum Reference: PHA 301: Systemic Pharmacology: Autonomic, Cardiovascular & Chemotherapeutic Agents (300 Level) • MDCN Profess...

Module 6 • Subtopic 2
Formative Assessment10 Points • 15 Mins

Antimicrobial Chemotherapy II: Protein Synthesis Inhibitors (Aminoglycosides, Macrolides, Tetracyclines): Formative Clinical Case Assessment

Assessment Protocol:10 Total Points•70% Passing Threshold•15 Mins Time Limit•Bloom's Taxonomy: Analyze & Evaluate

Authentic clinical vignette self-assessment evaluating semiology, diagnostic decision-making, and therapeutics for Antimicrobial Chemotherapy II: Protein Synthesis Inhibitors (Aminoglycosides, Macrolides, Tetracyclines).

Module 6 • Formative Assessment
Subtopic 1Document LectureOpen Access~27 min read

Antiparasitic & Antiviral Drugs: ACTs, Anthelmintics, Antiretrovirals (ART) & Direct-Acting Antivirals: Structural Principles & Pathophysiological Derangements

PHA 301 • 300L • Pharmacology • Chapter 7 • Lecture 1 Antiparasitic & Antiviral Drugs: ACTs, Anthelmintics, Antiretrovirals (ART) & Direct-Acting Antivirals: Structural Principles, Functional Architecture & Pathophysiological Derangements Curriculum Reference: PHA 301: Systemic Pharmacology: Autonomic, Cardiovascular & Chemotherapeutic Agents (300 Level) • Medi...

Module 7 • Subtopic 1•22,392 characters of authentic academic content
Subtopic 2Document Lecture

Antiparasitic & Antiviral Drugs: ACTs, Anthelmintics, Antiretrovirals (ART) & Direct-Acting Antivirals: Clinical Semiology, Differential Diagnosis & Evidence-Based Management

PHA 301 • 300L • Pharmacology • Chapter 7 • Lecture 2 Antiparasitic & Antiviral Drugs: ACTs, Anthelmintics, Antiretrovirals (ART) & Direct-Acting Antivirals: Clinical Semiology, Differential Diagnosis & Evidence-Based Bedside Management Curriculum Reference: PHA 301: Systemic Pharmacology: Autonomic, Cardiovascular & Chemotherapeutic Agents (300 Level) • MDCN P...

Module 7 • Subtopic 2
Formative Assessment10 Points • 15 Mins

Antiparasitic & Antiviral Drugs: ACTs, Anthelmintics, Antiretrovirals (ART) & Direct-Acting Antivirals: Formative Clinical Case Assessment

Assessment Protocol:10 Total Points•70% Passing Threshold•15 Mins Time Limit•Bloom's Taxonomy: Analyze & Evaluate

Authentic clinical vignette self-assessment evaluating semiology, diagnostic decision-making, and therapeutics for Antiparasitic & Antiviral Drugs: ACTs, Anthelmintics, Antiretrovirals (ART) & Direct-Acting Antivirals.

Module 7 • Formative Assessment
Subtopic 1Document LectureOpen Access~27 min read

Chemotherapy of Neoplasms: Alkylating Agents, Antimetabolites, Cytotoxics & Monoclonal Antibodies: Structural Principles & Pathophysiological Derangements

PHA 301 • 300L • Pharmacology • Chapter 8 • Lecture 1 Chemotherapy of Neoplasms: Alkylating Agents, Antimetabolites, Cytotoxics & Monoclonal Antibodies: Structural Principles, Functional Architecture & Pathophysiological Derangements Curriculum Reference: PHA 301: Systemic Pharmacology: Autonomic, Cardiovascular & Chemotherapeutic Agents (300 Level) • Medical Pharm...

Module 8 • Subtopic 1•22,291 characters of authentic academic content
Subtopic 2Document Lecture

Chemotherapy of Neoplasms: Alkylating Agents, Antimetabolites, Cytotoxics & Monoclonal Antibodies: Clinical Semiology, Differential Diagnosis & Evidence-Based Management

PHA 301 • 300L • Pharmacology • Chapter 8 • Lecture 2 Chemotherapy of Neoplasms: Alkylating Agents, Antimetabolites, Cytotoxics & Monoclonal Antibodies: Clinical Semiology, Differential Diagnosis & Evidence-Based Bedside Management Curriculum Reference: PHA 301: Systemic Pharmacology: Autonomic, Cardiovascular & Chemotherapeutic Agents (300 Level) • MDCN Profession...

Module 8 • Subtopic 2
Formative Assessment10 Points • 15 Mins

Chemotherapy of Neoplasms: Alkylating Agents, Antimetabolites, Cytotoxics & Monoclonal Antibodies: Formative Clinical Case Assessment

Assessment Protocol:10 Total Points•70% Passing Threshold•15 Mins Time Limit•Bloom's Taxonomy: Analyze & Evaluate

Authentic clinical vignette self-assessment evaluating semiology, diagnostic decision-making, and therapeutics for Chemotherapy of Neoplasms: Alkylating Agents, Antimetabolites, Cytotoxics & Monoclonal Antibodies.

Module 8 • Formative Assessment

Instructor

PAMCET Learning Team

PAMCET Learning Team

Institutional Course Curation · PAMCET

The PAMCET Learning Team is the institutional curriculum and content group behind course publishing on this platform. PAMCET (Professional and Academic Management Centre for Education and Training) is operated by Digitpen Hub Ltd, a company registered in Lagos, Nigeria. Courses credited to the PAMCET Learning Team are structured, organized, and published centrally by the platform rather than authored by a single named individual instructor — each course's syllabus, learning outcomes, and content are reviewed before publication under this institutional account. For questions about a specific course or to report a content issue, please use the platform's Help & Support or Contact Us pages.

Qualifications:

PAMCET Learning Team — Institutional Course Curation, Digitpen Hub Ltd

My Skills:

  • Curriculum Curation
  • Course Content Review
  • Learning Outcome Design
  • Course Publishing & Quality Assurance
  • Platform Content Operations

Reviews

No reviews available
PHA 301: Systemic Pharmacology: Autonomic, Cardiovascular & Chemotherapeutic Agents (300 Level)
Free$24.99100% Off
Certificate available separately for $7 after completion

Course Includes

8 Chapters
16 Lectures
1 week
Skill Level intermediate
Taught in English
Lifetime Access
Certification of Completion
Category: University - Medicine & Surgery
Share On

Download Syllabus & Study Guide

Receive the full lecture syllabus, reading list, and milestone schedule for PHA 301: Systemic Pharmacology: Autonomic, Cardiovascular & Chemotherapeutic Agents (300 Level).

By submitting, you agree to receive educational updates. You can unsubscribe anytime. Read our Privacy Policy.

PHA 301: Systemic Pharmacology: Autonomic, Cardiovascular & Chemotherapeutic Agents (300 Level) | PAMCET University — MBBS | PAMCET